Ftse Mib
34.339,32
0,55%
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
NASDAQ
16.346,26
0,27%
Bitcoin
62.932,77
-0,18%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC EPIRUS Biopharmaceuticals Inc (CE) (EPRSQ) EPIRUS Biopharmaceuticals Inc (CE) (EPRSQ) Notizie

EPRSQ

EPIRUS Biopharmaceuticals (CE) (EPRSQ)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:EPRSQ
DataOraFonteTitoloSimboloCompagnia
14/02/201718:06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
26/09/201615:34Edgar (US Regulatory)(25-NSE)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
01/08/201619:41Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
31/05/201622:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
10/05/201623:51Edgar (US Regulatory)Quarterly Report (10-q)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
09/05/201622:00GlobeNewswire Inc.EPIRUS Announces Reprioritization of Pipeline to Solely Focus on Biosimilars to Treat Rare Diseases and Key Leadership Change...USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
29/04/201613:01Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
29/03/201622:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
29/03/201612:10Edgar (US Regulatory)Annual Report (10-k)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
15/03/201621:38Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
15/03/201611:00GlobeNewswire Inc.EPIRUS Biopharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financial Results and Provides Business UpdateUSOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
11/03/201622:08Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
10/03/201601:46GlobeNewswire Inc.EPIRUS Biopharmaceuticals to Release Fourth Quarter and Fiscal Year 2015 Financial Results and Provide Business UpdateUSOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
01/03/201614:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
09/02/201613:00GlobeNewswire Inc.EPIRUS Biopharmaceuticals Initiates Pivotal Global Phase 3 Clinical Study for BOW015 (Infliximab Biosimilar)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
05/02/201622:01GlobeNewswire Inc.EPIRUS Biopharmaceuticals to Participate in Bloomberg Intelligence Healthcare Event on February 12USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
03/02/201615:00GlobeNewswire Inc.EPIRUS Biopharmaceuticals to Present at LEERINK Partners 5th Annual Global Healthcare ConferenceUSOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
22/12/201520:24Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
16/11/201521:38Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
16/11/201512:05GlobeNewswire Inc.EPIRUS Biopharmaceuticals Provides Clinical Program Update on BOW015 (Infliximab Biosimilar)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
16/11/201512:00GlobeNewswire Inc.EPIRUS Biopharmaceuticals Reports Third Quarter 2015 Financial Results & Provides Business UpdateUSOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
11/11/201522:05GlobeNewswire Inc.EPIRUS Biopharmaceuticals Reschedules Its Third Quarter 2015 Financial Results Conference Call and WebcastUSOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
10/11/201522:33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
10/11/201514:00GlobeNewswire Inc.EPIRUS Biopharmaceuticals Appoints Industry Veteran Vincent E. Aurentz as Chief Business OfficerUSOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
05/11/201514:00GlobeNewswire Inc.EPIRUS Biopharmaceuticals Joins Biosimilars Forum to Help Educate Patients and Healthcare Providers on Importance of Biosimil...USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
29/10/201512:00GlobeNewswire Inc.EPIRUS Biopharmaceuticals to Release Third Quarter 2015 Financial Results and Provide Business UpdateUSOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
22/09/201502:46GlobeNewswire Inc.EPIRUS Biopharmaceuticals Expands Biosimilar Pipeline and Capabilities Through Acquisition of BiocerosUSOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
20/07/201512:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
14/07/201512:00GlobeNewswireEPIRUS Biopharmaceuticals and Polpharma Group Enter Into a Multi-Product, Multi-Region, Profit-Sharing Collaboration to Advan...USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
13/07/201523:13Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:EPRSQEPIRUS Biopharmaceuticals Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:EPRSQ

La tua Cronologia

BIT
BPE
Bper Banca
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
NEXI
Nexi S.p.A
BIT
BAMI
Banco BPM
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
FBK
Finecobank
BIT
TIT
Telecom Italia
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network